Recording: NMIBC from intermediate to high risk: Current landscape and ongoing studies
This recording will focus on the evolving management of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC).
The recording aims to explain and explore the current definitions, treatment paradigms, and clinical dilemmas in daily practice.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 60 minutes |
By addressing ongoing challenges such as optimal risk stratification, treatment duration, and future therapeutic directions, the e-course will help urologists make informed decisions and prepare for innovations that are likely to reshape NMIBC care in the coming years.
Speakers:
- Dr. M. Moschini (IT)
- Dr. L.S. Mertens (NL)
- Dr. M.C. Mir Maresma (US)
- Dr. F. Soria (IT)
This recording is brought to you in collaboration with EAU Section of Oncological Urology.
Acknowledgment
This activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.